+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Reprogramming Market Size, Share & Trends Analysis Report by Technology (Sendai Virus-based Reprogramming, MRNA Reprogramming, Episomal Reprogramming), Application (Research, Therapeutic), End-use, Region, with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • April 2025
  • Region: Global
  • Grand View Research
  • ID: 5649372
REQUEST CUSTOMIZATION
Description Jump to:
The Cell Reprogramming Market was valued at USD 406.6 Million in 2024, and is projected to reach USD 664.2 Million by 2030, rising at a CAGR of 8.55%. Factors, such as increasing adoption of cell reprogramming in cancer research and growing focus on cell reprogramming, are expected to drive market growth. In addition, emphasis on collaborations and partnerships among key players is anticipated to boost market growth. Advancements in the mRNA reprogramming technique allow rapid, safe, and efficient generation of clinical-grade human iPS cells using somatic tissue. In addition, as mRNA is lower in size, the transfection process is simpler than other reprogramming vectors. When utilizing difficult-to-reprogram samples, mRNA reprogramming improves reprogramming efficiency by 1%.

Furthermore, this method can generate high-quality human iPS cells from somatic tissue more rapidly and safely, which increases the demand for mRNA reprogramming technology. Furthermore, there is the capability to reprogram human stem cells back to a naive state, allowing replication of the earliest developmental stages. For instance, in March 2022, researchers at the Babraham Institute identified key factors facilitating this reprogramming process. This new knowledge streamlines and expedites the generation of naive pluripotent stem cells for researchers. Moreover, cell reprogramming is experiencing growth due to significant government and public funding. This backing is a response to various benefits it offers to the healthcare sector, particularly in terms of its potential applications in medicine.

Furthermore, cell reprogramming has recently been repositioned from the lab to clinic by researchers. This shift is prominent in various clinical & academic research initiatives, encompassing regenerative medicine, disease modeling, and studies related to medication toxicity & drug discovery. The clinical utility of cell reprogramming, especially in regenerative medicine, has been significant. Increased strategic initiatives aimed at innovative product development through cell reprogramming is due to a growth in the research and academic institute segment. For instance, the California Institute for Regenerative Medicine funded research groups to advance cellular reprogramming into therapeutic applications with a clinical focus.

Cell Reprogramming Market Report Highlights

  • The mRNA reprogramming technology segment held the largest revenue share of 32.63% in 2024, due to the ease of use, speed, safety, and efficiency while generating high-quality human iPS cells from somatic tissue.
  • The research application segment led the market with a share of 67.30% in 2024. One of the main factors driving its growth include ongoing research in the field of cell reprogramming using stem cells.
  • The research & academic institute end-use segment held a revenue share of 67.30% in 2024. The growth is due to usage of cell reprogramming in a various clinical & academic research initiatives, including those involving regenerative therapies, disease modeling, and drug toxicity/drug discovery studies.
  • North America dominated the global industry in 2024, with a revenue share of 39.69%, owing to the presence of key players in this region.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Platform & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Platform & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1:
1.9.2. Objective 2:
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing focus on cell reprogramming
3.2.1.2. Increasing adoption of cell reprogramming in cancer research
3.2.1.3. Emphasis on collaborations and partnerships among key players
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges associated with iPSCs
3.2.2.2. Limited awareness regarding treatment option
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
4.1. Technology Segment Dashboard
4.2. Cell Reprogramming Market: Technology Movement Analysis
4.3. Sendai Virus-based Reprogramming
4.3.1. Sendai Virus-based Reprogramming Market, 2018-2030 (USD Million)
4.4. mRNA Reprogramming
4.4.1. mRNA Reprogramming Market, 2018-2030 (USD Million)
4.5. Episomal Reprogramming
4.5.1. Episomal Reprogramming Market, 2018-2030 (USD Million)
4.6. Others
4.6.1. Others Reprogramming Market, 2018-2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Application Segment Dashboard
5.2. Cell Reprogramming Market: Application Movement Analysis
5.3. Research
5.3.1. Research Market, 2018-2030 (USD Million)
5.4. Therapeutics
5.4.1. Therapeutics Market, 2018-2030 (USD Million)
Chapter 6. End-use Business Analysis
6.1. End Use Segment Dashboard
6.2. Cell Reprogramming Market: End-use Movement Analysis
6.3. Research & Academic Institutes
6.3.1. Research & Academic Institutes Market, 2018-2030 (USD Million)
6.4. Biotechnology & Pharmaceutical Companies
6.4.1. Biotechnology & Pharmaceutical Companies Market, 2018-2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Regional Dashboard
7.2. Cell Reprogramming Market Share by Region, 2018-2030
7.3. North America
7.3.1. North America Cell Reprogramming Market, 2018-2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. U.S. Cell Reprogramming Market, 2018-2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Canada Cell Reprogramming Market, 2018-2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Mexico Cell Reprogramming Market, 2018-2030 (USD Million)
7.4. Europe
7.4.1. Europe Cell Reprogramming Market, 2018-2030 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. UK Cell Reprogramming Market, 2018-2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Germany Cell Reprogramming Market, 2018-2030 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. France Cell Reprogramming Market, 2018-2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Italy Cell Reprogramming Market, 2018-2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Spain Cell Reprogramming Market, 2018-2030 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Denmark Cell Reprogramming Market, 2018-2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Sweden Cell Reprogramming Market, 2018-2030 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Norway Cell Reprogramming Market, 2018-2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Cell Reprogramming Market, 2018-2030 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Japan Cell Reprogramming Market, 2018-2030 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. China Cell Reprogramming Market, 2018-2030 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. India Cell Reprogramming Market, 2018-2030 (USD Million)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Australia Cell Reprogramming Market, 2018-2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Thailand Cell Reprogramming Market, 2018-2030 (USD Million)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. South Korea Cell Reprogramming Market, 2018-2030 (USD Million)
7.6. Latin America
7.6.1. Latin America Cell Reprogramming Market, 2018-2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Brazil Cell Reprogramming Market, 2018-2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Argentina Cell Reprogramming Market, 2018-2030 (USD Million)
7.7. MEA
7.7.1. MEA Cell Reprogramming Market, 2018-2030 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. South Africa Cell Reprogramming Market, 2018-2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Saudi Arabia Cell Reprogramming Market, 2018-2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. UAE Cell Reprogramming Market, 2018-2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Kuwait Cell Reprogramming Market, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Allele Biotechnology and Pharmaceuticals Inc.
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. ALSTEM
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. STEMCELL Technologies
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Merck KGaA
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Bio-Techne
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. REPROCELL Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Lonza
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. FUJIFILM Corporation (Fujifilm Cellular Dynamics)
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Mogrify Limited
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 4 Global Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 5 Global Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 6 Global Cell Reprogramming Market, By Region, 2018-2030 (USD Million)
Table 7 North America Cell Reprogramming Market, By Country, 2018-2030 (USD Million)
Table 8 North America Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 9 North America Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 10 North America Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 11 U.S. Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 12 U.S. Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 13 U.S. Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 14 Canada Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 15 Canada Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 16 Canada Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 17 Mexico Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 18 Mexico Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 19 Mexico Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 20 Europe Cell Reprogramming Market, By Country, 2018-2030 (USD Million)
Table 21 Europe Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 22 Europe Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 23 Europe Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 24 UK Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 25 UK Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 26 UK Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 27 Germany Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 28 Germany Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 29 Germany Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 30 France Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 31 France Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 32 France Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 33 Spain Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 34 Spain Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 35 Spain Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 36 Italy Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 37 Italy Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 38 Italy Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 39 Denmark Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 40 Denmark Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 41 Denmark Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 42 Norway Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 43 Norway Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 44 Norway Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 45 Sweden Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 46 Sweden Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 47 Sweden Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 48 Asia Pacific Cell Reprogramming Market, By Country, 2018-2030 (USD Million)
Table 49 Asia Pacific Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 50 Asia Pacific Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 51 Asia Pacific Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 52 China Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 53 China Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 54 China Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 55 Japan Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 56 Japan Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 57 Japan Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 58 India Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 59 India Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 60 India Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 61 South Korea Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 62 South Korea Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 63 South Korea Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 64 Australia Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 65 Australia Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 66 Australia Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 67 Thailand Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 68 Thailand Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 69 Thailand Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 70 Latin America Cell Reprogramming Market, By Country, 2018-2030 (USD Million)
Table 71 Latin America Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 72 Latin America Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 73 Latin America Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 74 Brazil Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 75 Brazil Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 76 Brazil Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 77 Argentina Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 78 Argentina Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 79 Argentina Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 80 MEA Cell Reprogramming Market, By Country, 2018-2030 (USD Million)
Table 81 MEA Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 82 MEA Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 83 MEA Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 84 South Africa Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 85 South Africa Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 86 South Africa Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 87 UAE Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 88 UAE Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 89 UAE Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 90 Saudi Arabia Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 91 Saudi Arabia Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 92 Saudi Arabia Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
Table 93 Kuwait Cell Reprogramming Market, By Technology, 2018-2030 (USD Million)
Table 94 Kuwait Cell Reprogramming Market, By Application, 2018-2030 (USD Million)
Table 95 Kuwait Cell Reprogramming Market, By End-use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain-based sizing & forecasting
Figure 6 Market formulation & validation
Figure 7 Cell Reprogramming market segmentation
Figure 8 Market snapshot
Figure 9 Market trends & outlook
Figure 10 Market driver relevance analysis (current & future impact)
Figure 11 Market restraint relevance analysis (current & future impact)
Figure 12 PESTEL analysis
Figure 13 Porter’s five forces analysis
Figure 14 Global cell reprogramming market: Technology outlook and key takeaways
Figure 15 Global cell reprogramming market: Technology movement analysis
Figure 16 Global cell reprogramming market, for sendai virus-based reprogramming, 2018-2030 (USD Million)
Figure 17 Global cell reprogramming market, for mRNA reprogramming, 2018-2030 (USD Million)
Figure 18 Global cell reprogramming market, for episomal reprogramming, 2018-2030 (USD Million)
Figure 19 Global cell reprogramming market, for others, 2018-2030 (USD Million)
Figure 20 Global cell reprogramming market: Application outlook and key takeaways
Figure 21 Global cell reprogramming market: Application movement analysis
Figure 22 Global cell reprogramming market, for research, 2018-2030 (USD Million)
Figure 23 Global cell reprogramming market, for therapeutic, 2018-2030 (USD Million)
Figure 24 Global cell reprogramming market: End-use outlook and key takeaways
Figure 25 Global cell reprogramming market: End-use movement analysis
Figure 26 Global cell reprogramming market, for research & academic institutes, 2018-2030 (USD Million)
Figure 27 Global cell reprogramming market, for biotechnology & pharmaceutical companies, 2018-2030 (USD Million)
Figure 28 Regional marketplace: Key takeaways
Figure 29 Regional outlook, 2022 & 2030
Figure 30 North America cell reprogramming market, 2018-2030 (USD Million)
Figure 31 U.S. Key country dynamics
Figure 32 U.S. cell reprogramming market, 2018-2030 (USD Million)
Figure 33 Canada Key country dynamics
Figure 34 Canada cell reprogramming market, 2018-2030 (USD Million)
Figure 35 Mexico Key country dynamics
Figure 36 Mexico cell reprogramming market, 2018-2030 (USD Million)
Figure 37 Europe cell reprogramming market, 2018-2030 (USD Million)
Figure 38 Germany Key country dynamics
Figure 39 Germany cell reprogramming market, 2018-2030 (USD Million)
Figure 40 UK Key country dynamics
Figure 41 UK cell reprogramming market, 2018-2030 (USD Million)
Figure 42 France Key country dynamics
Figure 43 France cell reprogramming market, 2018-2030 (USD Million)
Figure 44 Italy Key country dynamics
Figure 45 Italy cell reprogramming market, 2018-2030 (USD Million)
Figure 46 Spain Key country dynamics
Figure 47 Spain cell reprogramming market, 2018-2030 (USD Million)
Figure 48 Denmark Key country dynamics
Figure 49 Denmark cell reprogramming market, 2018-2030 (USD Million)
Figure 50 Sweden Key country dynamics
Figure 51 Sweden cell reprogramming market, 2018-2030 (USD Million)
Figure 52 Norway Key country dynamics
Figure 53 Norway cell reprogramming market, 2018-2030 (USD Million)
Figure 54 Asia Pacific cell reprogramming market, 2018-2030 (USD Million)
Figure 55 Japan Key country dynamics
Figure 56 Japan cell reprogramming market, 2018-2030 (USD Million)
Figure 57 China Key country dynamics
Figure 58 China cell reprogramming market, 2018-2030 (USD Million)
Figure 59 India Key country dynamics
Figure 60 India cell reprogramming market, 2018-2030 (USD Million)
Figure 61 Australia Key country dynamics
Figure 62 Australia cell reprogramming market, 2018-2030 (USD Million)
Figure 63 South Korea Key country dynamics
Figure 64 South Korea cell reprogramming market, 2018-2030 (USD Million)
Figure 65 Thailand Key country dynamics
Figure 66 Thailand cell reprogramming market, 2018-2030 (USD Million)
Figure 67 Latin America cell reprogramming market, 2018-2030 (USD Million)
Figure 68 Brazil Key country dynamics
Figure 69 Brazil cell reprogramming market, 2018-2030 (USD Million)
Figure 70 Argentina Key country dynamics
Figure 71 Argentina cell reprogramming market, 2018-2030 (USD Million)
Figure 72 Middle East and Africa cell reprogramming market, 2018-2030 (USD Million)
Figure 73 South Africa Key country dynamics
Figure 74 South Africa cell reprogramming market, 2018-2030 (USD Million)
Figure 75 Saudi Arabia Key country dynamics
Figure 76 Saudi Arabia cell reprogramming market, 2018-2030 (USD Million)
Figure 77 UAE Key country dynamics
Figure 78 UAE cell reprogramming market, 2018-2030 (USD Million)
Figure 79 Kuwait Key country dynamics
Figure 80 Kuwait cell reprogramming market, 2018-2030 (USD Million)

Companies Mentioned

The companies profiled in this Cell Reprogramming market report include:
  • Thermo Fisher Scientific Inc.
  • Allele Biotechnology and Pharmaceuticals Inc.
  • ALSTEM
  • STEMCELL Technologies
  • Merck KGaA
  • Bio-Techne
  • REPROCELL Inc.
  • Lonza
  • FUJIFILM Corporation (Fujifilm Cellular Dynamics)
  • Mogrify Limited

Table Information

Report AttributeDetails
No. of Pages120
PublishedApril 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 406.6 Million
Forecasted Market Value ( USD ) by 2030 $ 664.2 Million
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cell Reprogramming - Global Strategic Business Report - Product Image

Cell Reprogramming - Global Strategic Business Report

  • Report
  • 369 Pages
  • Global
From
Cell Reprogramming Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cell Reprogramming Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Cell Reprogramming Market - Global Forecast 2025-2032 - Product Image

Cell Reprogramming Market - Global Forecast 2025-2032

  • Report
  • 197 Pages
  • Global
From
2025 Global Forecast for Cell Reprogramming (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Cell Reprogramming (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.